
About Medeloop
Medeloop is a Healthcare company based in Palo Alto (United States) founded in 2021 by Rene Caissie. Drug discovery services are offered by Medeloop as a CRO. Medeloop has raised $23.5 million across 2 funding rounds from investors including Icon Ventures, Inovia Capital and General Catalyst. Its chief executive, as recorded, is Rene Caissie. Medeloop offers products and services including Analytics Genius, Studies Genius, and Grants Genius. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Cell and Molecular Biology. Its legal entity is MEDELOOP INC. Its competitors include Hyku Biosciences, Centivax and Biolexis Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Medeloop was established in 2021 in Palo Alto, United States, as a contract research organization in the biotechnology sector. Drug discovery services are provided to support pharmaceutical development. Operations are centered on advancing research processes for clients. The company is led by co-founder and CEO Rene Caissie. Focus remains on efficient, data-driven solutions in the life sciences field.
- Headquarters Palo Alto, United States
- Founders Rene Caissie
- SectorsHealthcare
- Website medeloop.ai
- Social LinkedIn
- Legal Name Medeloop Inc
- Total Equity Funding$23.5M (USD)
in 2 rounds
- Latest Funding Round$15.5M (USD), Series A
Oct 2024
- InvestorsIcon Ventures
& 9 more
Products & Services of Medeloop
Medeloop offers a comprehensive portfolio of products and services, including Analytics Genius, Studies Genius, and Grants Genius.
AI tool for analyzing datasets without coding and extracting insights
Platform for collecting, monitoring, and automating study data
AI for matching grants and generating proposals quickly
Funding Insights of Medeloop
Medeloop has successfully raised a total of $23.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.5M
- Total Rounds 2
- Last Round Series A β $15.5M
- First Round $8M
(Sep 2023)
- Investors Count 10
All 2 funding rounds of Medeloop with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $15.5M | Series A | β | Inovia Capital | |
| Sep 2023 | $8M | Seed | β | General Catalyst |
10 investors in total: 8 institutional and 2 angel.
Investors in Medeloop
Medeloop has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Icon Ventures, Inovia Capital and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in early-stage technology companies by Inovia Capital. | inovia.vc | Montreal, Canada | ||
Sector-agnostic growth stage VC investment company funding companies in the US and Asia | 1992 | iconventures.com | Palo Alto, United States | |
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Seed-stage investments in technology companies are made by Maven Ventures. | mavenventures.com | Palo Alto, United States | ||
Healthier Capital is focused on healthcare technology venture investments. | healthiercapital.com | |||
Operational excellence and financial consulting are provided by CFO Advisors. | cfoadvisors.com | |||
Seed & early stage sector-agnostic VC firm funding companies in the US | ovofund.com | Palo Alto, United States | ||
KF Ken Frazier | unknown_10e92a1d1efa4bc89 | |||
LG Linda Grais | Angel investor and advisor, focused on early-stage Indian startups. | unknown_f7d33a31ad5b4d439 | ||
Up2 Foundation is focused on developing servant leaders through media and events. | up2foundation.org | Lakewood, United States |
Investor details for Medeloop
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medeloop
17 people are tracked at Medeloop (6 in leadership, 11 in team).
| Name | Role | Group |
|---|---|---|
Rene Caissie | Co-Founder & CEO | Leadership |
Ashley Moseby | Head Of Sales | Leadership |
Santiago C. | VP Of Engineering | Leadership |
Lauren Green | Chief Of Staff | Leadership |
Santiago Cardenas | VP Of Engineering | Leadership |
Alex Wu | Head Of Finance & Strategy | Leadership |
Jose Lavrador | Senior Software Engineer | Team |
Vishaal Yalamanchali | Machine Learning Engineer | Team |
Boqian Cheng | Senior Mobile Engineer | Team |
Rene Leyva | Senior Software Engineer | Team |
Kaci Madden | Product Manager | Team |
Yorick Chern | Machine Learning Engineer | Team |
Avi Udash | Founding Software Engineer | Team |
Olushola Adedokun | Software Engineering Manager | Team |
Daniela Cappa | Executive Assistant | Team |
Mohamed Lamouchi | Software Engineering Team Lead | Team |
Oliver Perez | Senior Mobile Engineer | Team |
Complete people profiles for Medeloop
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Medeloop
3 dated milestones of Medeloop across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Medeloop is founded.
- Funding First funding round of $8.0M.
- Funding Latest funding round, Series A, of $15.5M.
Competitors of Medeloop
Medeloop has 3 listed competitors in our database, 3 of them funded. They include Hyku Biosciences, Centivax and Biolexis Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hykubiosciences.com | 2023 | Lexington, United States | $56M | Covalent medicines platform is advanced for drug discovery targeting proteins. | ||
| centivax.com | 2019 | San Francisco, United States | $55M | Drug discovery services are provided to pharmaceutical and biotech clients. | ||
| biolexistx.com | 2021 | Salt Lake, United States | $12.5M | CRO focused on drug discovery of small molecule therapeutics |
Detailed competitors of Medeloop
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medeloop
The website of Medeloop (medeloop.ai) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 112.6% vs previous month
Websites whose visitors overlap most with Medeloop. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthverity.com | 100% | 10.2K | #2,336,457 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Medeloop (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medeloop
Complete news archive for Medeloop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medeloop
Medeloop was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Medeloop is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Rene Caissie is the CEO of Medeloop, as recorded in our data. They have also founded this company.
Medeloop is a funded company, having raised a total of $23.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $8M, raised on Sep 2023.
Medeloop was established in 2021 in Palo Alto, United States, as a contract research organization in the biotechnology sector. Drug discovery services are provided to support pharmaceutical development. Operations are centered on advancing research processes for clients. The company is led by co-founder and CEO Rene Caissie. Focus remains on efficient, data-driven solutions in the life sciences field.
Medeloop's top competitors include Centivax, Hyku Biosciences and Biolexis Therapeutics.
Medeloop offers Analytics Genius, Studies Genius, and Grants Genius.
Medeloop has 10 investors. Key investors include Icon Ventures, Inovia Capital, General Catalyst, Maven Ventures, and Healthier Capital.
Medeloop operates through Medeloop Inc.
